Тёмный
No video :(

Survaxm Vaccine For Glioblastoma 

musellafoundation
Подписаться 1,8 тыс.
Просмотров 1,2 тыс.
50% 1

Presented as part of the Musella Foundations' Brain Tumor Webinar Series.
Speaker: Michael Ciesielski, PhD, Chief Executive Officer of MimiVax, LLC
Presented on 7/18/23

Опубликовано:

 

5 сен 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 6   
@danielregufe
@danielregufe 11 месяцев назад
Hello. Is there any expectation of testing this vaccine in Brazil?
@MohaMoha-dq5qj
@MohaMoha-dq5qj 7 месяцев назад
Hi and thanks for informative presentation. I have gbm that was diagnosed in February 2023. I had surgery followed by radiation and temozolomide for 40 days. I had a good recovery. From July to December 23 i had chemo temozolimide higher doze. But, in decemer 23 i had an mri that a recurrence and doctor prescribed avastin and irinotecan for six sessions each taken every two weeks. Tolerance has been relevatly good. My query is whether is it possible to participate in the these clinical trials after current avastin/ irinotecan?
@musellafoundation
@musellafoundation 7 месяцев назад
Contact the clinical trial center closed to you and ask. If they say no, ask about expanded access.
@pw2563
@pw2563 9 месяцев назад
Can this be used just after a patient starts using Optune or is it limited to patients who just completed radiation? How does someone get accepted to clinical trial?
@jamesbelvin1271
@jamesbelvin1271 Год назад
So what is the current progress with this therapy? Does it work?
@musellafoundation
@musellafoundation Год назад
It looks like it works. It is in the final stages of trials before it can apply for fda approval
Далее
Gallium Maltoate for Brain Tumors
41:33
Просмотров 758
Sonodynamic Therapy For High Grade Brain Tumors
59:07
Просмотров 1,5 тыс.
Science Presentation - SNL
4:54
Просмотров 20 млн
Glioblastoma: State of the Art Treatment in 2021
1:05:52
Glioblastoma: From Diagnosis to Treatment
1:04:59
Просмотров 38 тыс.